The chromatin response to double-strand DNA breaks and their repair

R Aleksandrov, R Hristova, S Stoynov, A Gospodinov - Cells, 2020 - mdpi.com
Cellular DNA is constantly being damaged by numerous internal and external mutagenic
factors. Probably the most severe type of insults DNA could suffer are the double-strand …

Antitumor activity of rutaecarpine in human colorectal cancer cells by suppression of wnt/β-catenin signaling

WS Byun, ES Bae, WK Kim, SK Lee - Journal of Natural Products, 2022 - ACS Publications
Alkaloids derived from natural products have been traditionally used to treat various
diseases, including cancers. Rutaecarpine (1), a β-carboline-type alkaloid obtained from …

Antitumor activity of pulvomycin via targeting activated-STAT3 signaling in docetaxel-resistant triple-negative breast cancer cells

WS Byun, ES Bae, J Cui, HJ Park, DC Oh, SK Lee - Biomedicines, 2021 - mdpi.com
Although docetaxel-based regimens are common and effective for early-stage triple-
negative breast cancer (TNBC) treatment, acquired drug resistance frequently occurs …

Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics

JJ Mandumpala, S Baby, AA Tom, C Godugu… - Life sciences, 2022 - Elsevier
Triple-negative breast cancer (TNBC) is a particularly lethal subtype of breast cancer owing
to its heterogeneity, high drug resistance, poor prognosis and lack of therapeutic targets …

A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction

SK Park, WS Byun, S Lee, YT Han, YS Jeong… - Biochemical …, 2020 - Elsevier
Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer,
characterized by the lack of expression of estrogen receptor, progesterone receptor, and …

Antitumor activity of asperphenin B by induction of apoptosis and regulation of glyceraldehyde-3-phosphate dehydrogenase in human colorectal cancer cells

WS Byun, ES Bae, SC Park, WK Kim… - Journal of Natural …, 2021 - ACS Publications
Colorectal cancer (CRC) is a common and intractable malignancy with a high mortality risk.
Conventional chemotherapeutics are effective for patients with early stage CRC, but the …

Synthesis and biological activity of selenopsammaplin A and its analogues as antitumor agents with DOT1L inhibitory activity

HJ Han, WS Byun, GH Lee, WK Kim, K Jang… - Bioorganic & medicinal …, 2021 - Elsevier
Disruptor of telomeric silencing-1 like (DOT1L) is a histone H3 methyltransferase which
specifically catalyzes the methylation of histone H3 lysine-79 residue. Recent findings …

[HTML][HTML] DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma

P Li, Z Zhang, P Sun - Journal of Cancer, 2024 - ncbi.nlm.nih.gov
To assess telomere silencing 1-like (DOTIL) gene expression within gastric cancer (GC)
tissues as well as its function of promoting cancer stem cell (CSC)-mediated epithelial …

Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics

A Das, P Agarwal, GK Jain, G Aggarwal… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Background: Triple-Negative Breast Cancer (TNBC) is the most aggressive form of Breast
Cancer (BC), with high rates of metastasis and recurrence and limited treatment options …

Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer

WS Byun, GH Lee, H Park, SK Lee - Pharmaceuticals, 2020 - mdpi.com
Due to a lack of hormone receptors, current treatment strategies for triple-negative breast
cancer (TNBC) are limited with frequent disease recurrence and metastasis. Recent findings …